A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.

Sedat Yildirim Akif Dogan Goncagul Akdag Eyyüp Cavdar Oguzcan Kinikoglu Sila Oksuz Hacer Sahika Yildiz Aysun Kucukoz Uzun Deniz Işık Heves Surmeli Tugba Basoglu Tuylu Ozlem Nuray Sever Hatice Odabaş Mahmut Emre Yildirim Nedim Turan

Published in: Cancers (2024)

In this study, we observed that the LA index independently predicts OS and PFS in immunotherapy-treated metastatic NSCLC patients. Its ease of application, low cost, and noninvasive nature make it a potential guide for clinicians in predicting treatment responses and survival.

Keyphrases

small cell lung cancer
end stage renal disease
newly diagnosed
ejection fraction
squamous cell carcinoma
low cost
prognostic factors
peritoneal dialysis
risk assessment
climate change
human health